Propanc Biopharma, Inc.

Latest News

Apr 10, 2018

Propanc Biopharma Completes Scientific Advice Meeting with MHRA

Company Receives Guidance on the Investigational Medicinal Product Manufacturing Program for PRP. MELBOURNE, Australia, April 10, 2018 /PRNewswire/ -- Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the…

View All Press Releases

Mar 14, 2018

Propanc Biopharma Completes Successful Reproduction Run for PRP

Feb 20, 2018

Propanc Biopharma Receives Allowance of Key Patent Application in the EU

Feb 12, 2018

Propanc Biopharma Provides Shareholder Update and Goals for 2018
Latest Publication Antitumour efficacy of chymotrypsinogen and trypsinogen View All Publications
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer
Seethru Equity